ClinicalTrials.Veeva

Menu

Intestinal Microbiome and Chronic Inflammatory Bowel Disease

T

Turku University Hospital (TYKS)

Status

Unknown

Conditions

Colitis

Treatments

Other: Observational

Study type

Observational

Funder types

Other

Identifiers

NCT02768038
TurkuUH2

Details and patient eligibility

About

The aim is to examine the role of intestinal microbiota in the pathogenesis of chronic inflammatory bowel diseases (IBD)

Full description

IBD patients to whom colonoscopy is performed will be recruited. Mucosal specimens from large intestine and terminal ileum will be collected as well as stool specimens. The microbiota will be analyzed at the microbiology laboratory and the results will be correlated with endoscopical, laboratory and histopathological findings.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • IBD

Exclusion criteria

  • patient refusal to participate

Trial contacts and locations

1

Loading...

Central trial contact

Markku Voutilainen, Prof.; Mervi Tenhami, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems